{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:16:21Z","timestamp":1767842181582,"version":"3.49.0"},"reference-count":106,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Adolescent Health"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jadohealth.2011.07.003","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T21:19:08Z","timestamp":1315689548000},"page":"467-475","source":"Crossref","is-referenced-by-count":48,"title":["The Efficacy and Safety of the Quadrivalent Human Papillomavirus 6\/11\/16\/18 Vaccine Gardasil"],"prefix":"10.1016","volume":"49","author":[{"given":"Richard M.","family":"Haupt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather L.","family":"Sings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jadohealth.2011.07.003_bib1","series-title":"Clinical Virology","first-page":"557","article-title":"Papillomavirus","author":"Bonnez","year":"2002"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.ygyno.2010.01.024","article-title":"Pathology and epidemiology of HPV infection in females","volume":"117","author":"Stanley","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Mu\u00f1oz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"HPV in the etiology of human cancer","volume":"24","author":"Mu\u00f1oz","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib6","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(09)61248-4","article-title":"Efficacy of human papillomavirus (HPV)-16\/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women","volume":"374","author":"Paavonen","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib7","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","article-title":"Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions","volume":"356","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jnci\/djp534","article-title":"Impact of human papillomavirus (HPV)-6\/11\/16\/18 vaccine on all HPV-associated genital diseases in young women","volume":"102","author":"Mu\u00f1oz","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 3","key":"10.1016\/j.jadohealth.2011.07.003_bib10","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","article-title":"The burden of HPV-related cancers","volume":"24","author":"Parkin","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6601024","article-title":"Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: A meta-analysis","volume":"89","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib12","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib13","series-title":"Cancer incidence, mortality and prevalence worldwide","author":"Ferlay","year":"2002"},{"issue":"Suppl 3","key":"10.1016\/j.jadohealth.2011.07.003_bib14","article-title":"HPV vaccine use in the developing world","volume":"24","author":"Kane","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib15","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1093\/annonc\/mdm079","article-title":"Burden of cervical cancer in Europe: Estimates for 2004","volume":"18","author":"Arbyn","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/jnci\/djj067","article-title":"Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention","volume":"98","author":"Castellsagu\u00e9","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib18","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/cncr.20064","article-title":"Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976\u20132000","volume":"100","author":"Wang","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib19","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/cncr.20877","article-title":"Mortality trends for cervical squamous and adenocarcinoma in the United States \u2212 Relation to incidence and survival","volume":"103","author":"Sherman","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib20","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U","article-title":"International trends in the incidence of cervical cancer: I","volume":"75","author":"Vizcaino","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/ijc.20678","article-title":"Cervical cancer in the Netherlands 1989\u20131998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women","volume":"113","author":"Bulk","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib22","article-title":"Handbooks of Cancer Prevention","volume":"Vol 9","year":"2004"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib23","first-page":"912","article-title":"A comparison of adenocarcinoma and squamous cell carcinoma of the cervix","volume":"77","author":"Hopkins","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis","volume":"88","author":"Clifford","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib25","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen?","volume":"111","author":"Mu\u00f1oz","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib26","series-title":"Modern Colposcopy, Textbook, and Atlas","author":"Ferris","year":"2004"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0020-7292(00)90001-8","article-title":"FIGO Staging Classifications and Clinical Practice Guidelines in the management of gynecologic cancers","volume":"70","author":"Benedet","year":"2000","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib28","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.bjc.6602049","article-title":"Cervical HPV infection and neoplasia in a large population-based prospective study: The Manchester cohort","volume":"91","author":"Peto","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib29","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0002-9378(03)00413-7","article-title":"A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib30","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0002-9378(03)00418-6","article-title":"Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance","volume":"188","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1158\/1055-9965.EPI-07-0741","article-title":"The case for a gender-neutral (universal) human papillomavirus vaccination policy in the United States: Point","volume":"17","author":"Giuliano","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib33","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1001\/jama.271.23.1866","article-title":"Interim guidelines for management of abnormal cervical cytology","volume":"271","author":"Kurman","year":"1994","journal-title":"JAMA"},{"issue":"Suppl","key":"10.1016\/j.jadohealth.2011.07.003_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/jcb.240590909","article-title":"Perspective on cervical cancer: Why prevent?","volume":"23","author":"Morrow","year":"1995","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib35","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1016\/S0264-410X(01)00134-7","article-title":"An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA) in adults: Safety, tolerability, and immunogenicity","volume":"19","author":"Lingl\u00f6f","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ajog.2004.01.042","article-title":"The health care costs of cervical human papillomavirus-related disease","volume":"191","author":"Insinga","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib37","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1158\/1055-9965.EPI-04-0812","article-title":"Human papillomavirus genotype distribution in low-grade cervical lesions: Comparison by geographic region and with cervical cancer","volume":"14","author":"Clifford","year":"2005","journal-title":"Cancer Epidemiol Bios Prev"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib38","first-page":"c3493","article-title":"Four year efficacy of prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine against low-grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: Randomised controlled trial","volume":"340","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib39","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1158\/1940-6207.CAPR-09-0031","article-title":"A pooled analysis of continued prophylactic efficacy of quadrivalent HPV (types 6\/11\/16\/18) vaccine against high-grade cervical and external genital lesions","volume":"2","author":"Kjaer","year":"2009","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","article-title":"Classification of papillomaviruses","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib43","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The Impact of quadrivalent HPV (type 6\/11\/16\/18) L1 VLP vaccine on infection and disease due to oncogenic non-vaccine HPV types in generally HPV naive women aged 16\u201326","volume":"199","author":"Brown","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib44","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/ijc.24116","article-title":"Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis","volume":"124","author":"De Vuyst","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib46","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.jadohealth.2010.01.010","article-title":"Human papillomavirus-related disease in men: Not just a women's issue","volume":"46","author":"Palefsky","year":"2010","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib47","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: The surveillance, epidemiology, and end results experience, 1973\u20132000","volume":"101","author":"Johnson","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib48","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.247.14.1988","article-title":"Correlates of homosexual behavior and the incidence of anal cancer","volume":"247","author":"Daling","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib49","first-page":"1","article-title":"Breast and cervical cancer surveillance, United States, 1973\u20131987","volume":"41","author":"Qualters","year":"1992","journal-title":"MMWR CDC Surveill Summ"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib50","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/infdis\/jiq015","article-title":"External genital HPV prevalence and associated factors among heterosexual men on five continents","volume":"203","author":"Vardas","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/infdis\/jiq016","article-title":"Prevalence and risk factors for HPV infection in HIV serogenative men who have sex with men","volume":"203","author":"Goldstone","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib52","author":"Goldstone"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib53","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","article-title":"Worldwide burden of gynaecological cancer: The size of the problem","volume":"20","author":"Sankaranarayanan","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib54","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/01.AOG.0000210268.57527.a1","article-title":"Trends in the incidence of invasive and in situ vulvar carcinoma","volume":"107","author":"Judson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ygyno.2008.01.041","article-title":"New aspects of vulvar cancer: Changes in localization and age of onset","volume":"109","author":"Hampl","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00001703-200202000-00007","article-title":"Epidemiology, diagnosis and treatment of vulvar intraepithelial neoplasia","volume":"14","author":"Joura","year":"2002","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib58","series-title":"EAGC Course Book on Colposcopy","first-page":"120","article-title":"Colposcopy of the vagina","author":"Winter-Roach","year":"2004"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib59","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00006250-198609000-00008","article-title":"Vaginal intraepithelial neoplasia \u2212 Biologic aspects and management","volume":"68","author":"Lenehan","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib60","first-page":"294","article-title":"Multifocal squamous neoplasia of the female genital tract: significance of human papillomavirus infection of the vagina after hysterectomy","volume":"70","author":"Schneider","year":"1987","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib62","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/1097-0142(19910701)68:1<195::AID-CNCR2820680135>3.0.CO;2-L","article-title":"Natural history of vaginal intraepithelial neoplasia","volume":"68","author":"Aho","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib64","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1097\/01.AOG.0000245786.86267.80","article-title":"Effect of human papillomavirus vaccines on vulvar, vaginal, and anal intraepithelial lesions and vulvar cancer","volume":"108","author":"Hampl","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib65","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0029-7844(95)00045-S","article-title":"Prognostic significance of human papillomavirus DNA in vulvar carcinoma","volume":"85","author":"Monk","year":"1995","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib66","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajog.2008.03.064","article-title":"The economic burden of noncervical human papillomavirus disease in the United States","volume":"198","author":"Hu","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib67","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: Diagnosis, treatment and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib68","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.55.091902.103520","article-title":"Human papillomavirus vaccines and prevention of cervical cancer","volume":"55","author":"Jansen","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib69","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/597071","article-title":"Natural history of genital warts: Analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine","volume":"199","author":"Garland","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib70","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajog.2008.03.056","article-title":"The economic impact of HPV vaccines: Not just cervical cancer","volume":"198","author":"Myers","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib71","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/00007435-200111000-00006","article-title":"Condylomata acuminata (genital warts) \u2212 Patient demographics and treating physicians","volume":"28","author":"Fleischer","year":"2001","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib72","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/01.olq.0000145851.76025.ad","article-title":"Rate and predictors of new genital warts claims and genital warts-related healthcare utilization among privately insured patients in the United States","volume":"31","author":"Koshiol","year":"2004","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib74","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1258\/0956462961917618","article-title":"The psychosocial impact of human papillomavirus infection: Implications for health care providers","volume":"7","author":"Clarke","year":"1996","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib75","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1258\/0956462981921143","article-title":"An international survey of patients with genital warts: Perceptions regarding treatment and impact on lifestyle","volume":"9","author":"Maw","year":"1998","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib76","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/375074","article-title":"The health and economic burden of genital warts in a set of private health plans in the United States","volume":"36","author":"Insinga","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib77","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1258\/0956462041558168","article-title":"The costs of treating external genital warts in England and Wales: A treatment pattern analysis","volume":"15","author":"Langley","year":"2004","journal-title":"Int J STD AIDS"},{"issue":"Suppl 3","key":"10.1016\/j.jadohealth.2011.07.003_bib78","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.vaccine.2006.06.015","article-title":"Burden and management of non-cancerous HPV-related conditions: HPV-6\/11 disease","volume":"24","author":"Lacey","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib79","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1542\/peds.2006-1555","article-title":"Recurrent respiratory papillomatosis in children: Masquerader of common respiratory diseases","volume":"118","author":"Zacharisen","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib80","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hed.20491","article-title":"Juvenile recurrent respiratory papillomatosis: Still a mystery disease with difficult management","volume":"29","author":"Stamataki","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib81","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.ijporl.2006.06.006","article-title":"Prevention of recurrent respiratory papillomatosis: Role of HPV vaccination","volume":"70","author":"Freed","year":"2006","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib82","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1002\/cncr.23743","article-title":"Burden of invasive squamous cell carcinoma of the penis in the United States, 1998\u20132003","volume":"113","author":"Hernandez","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib83","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0002-9440(10)62506-0","article-title":"Detection and typing of human papillomavirus DNA in penile carcinoma: Evidence for multiple independent pathways of penile carcinogenesis","volume":"159","author":"Rubin","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib84","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jcp.2008.063149","article-title":"Human papillomavirus prevalence and type distribution in penile carcinoma","volume":"62","author":"Miralles-Guri","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib85","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/154405910708600202","article-title":"The epidemiology and risk factors of head and neck cancer: A focus on human papillomavirus","volume":"86","author":"Ragin","year":"2007","journal-title":"J Dent Res"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib86","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1158\/1078-0432.CCR-09-0784","article-title":"Human papillomavirus in head and neck cancer: Its role in pathogenesis and clinical implications","volume":"15","author":"Chung","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib87","doi-asserted-by":"crossref","first-page":"c1439","DOI":"10.1136\/bmj.c1439","article-title":"Oropharyngeal carcinoma related to human papillomavirus","volume":"340","author":"Mehanna","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib88","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1158\/1055-9965.EPI-04-0551","article-title":"Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review","volume":"14","author":"Kreimer","year":"2005","journal-title":"Cancer Epidemiol Bios Prev"},{"issue":"Suppl 1","key":"10.1016\/j.jadohealth.2011.07.003_bib89","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1601-0825.2011.01792.x","article-title":"Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: A systematic review","volume":"17","author":"Syrj\u00e4nen","year":"2011","journal-title":"Oral Dis"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib90","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/sj.bjc.6603695","article-title":"Prophylactic HPV vaccines: Prospects for eliminating ano-genital cancer","volume":"96","author":"Stanley","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib91","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16 and 18","volume":"24","author":"Villa","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib92","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1086\/521679","article-title":"Impact of baseline covariates on the immunogenicity of a quadrivalent (types 6, 11, 16, and 18) human papillomavirus virus-like-particle vaccine","volume":"196","author":"Giuliano","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib93","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1128\/CDLI.10.1.108-115.2003","article-title":"Simultaneous quantitation of antibodies to neutralizing epitopes on virus-like particles for human papillomavirus types 6, 11, 16 and 18 by a multiplexed luminex assay","volume":"10","author":"Opalka","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib94","unstructured":"Brown DR, Garland SM, Ferris DG, et al. The humoral response to Gardasil(R) over four years as defined by total IgG and competitive luminex immunoassay. Hum Vaccin (in press)."},{"key":"10.1016\/j.jadohealth.2011.07.003_bib95","first-page":"877","article-title":"Time course of humoral and cell-mediated immune responses to human papillomavirus type 16 in infected women","volume":"9","author":"Nakagawa","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib96","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1016\/j.vaccine.2007.03.049","article-title":"Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6\/11\/16\/18L1 virus-like-particle vaccine","volume":"25","author":"Olsson","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib97","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","article-title":"High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18L1 virus-like particle vaccine through 5 years of follow-up","volume":"95","author":"Villa","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib98","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/hv.5.10.9515","article-title":"Evaluation of quadrivalent HPV 6\/11\/16\/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection","volume":"5","author":"Olsson","year":"2009","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib99","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","article-title":"Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women","volume":"118","author":"Block","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib101","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: Use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib103","first-page":"1018","article-title":"National, state, and local area vaccination coverage among adolescents aged 13\u201317 years \u2013 United States, 2009","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib104","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1542\/peds.2009-2336","article-title":"Safety, tolerability, and immunogenicity of Gardasil given concomitantly with menactra and adacel","volume":"125","author":"Reisinger","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.vaccine.2007.11.043","article-title":"Safety and immunogenicity of co-administered quadrivalent human papillomavirus (HPV)-6\/11\/16\/18 L1 virus-like particle (VLP) and hepatitis B (HBV) vaccines","volume":"26","author":"Wheeler","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/INF.0b013e3181b77906","article-title":"Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6; 11, 16, and 18) l1 virus-like particle vaccine","volume":"29","author":"Block","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib107","first-page":"1","article-title":"General recommendations on immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib108","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","article-title":"Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib110","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1016\/j.vaccine.2009.09.097","article-title":"Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far","volume":"27","author":"Agorastos","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib111","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1016\/j.vaccine.2010.02.019","article-title":"Post-licensure monitoring of HPV vaccine in the United States","volume":"28","author":"Markowitz","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib112","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1016\/j.vaccine.2010.04.070","article-title":"A summary of the post-licensure surveillance initiatives for GARDASIL\/SILGARD(R)","volume":"28","author":"Bonanni","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib113","first-page":"457","article-title":"Interim estimates of human papillomavirus vaccination coverage in the school-based program in Australia","volume":"32","author":"Brotherton","year":"2008","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib114","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/sti.2009.037788","article-title":"Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young women","volume":"85","author":"Fairley","year":"2009","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1473-3099(10)70225-5","article-title":"Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: Analysis of National Sentinel Surveillance Data","volume":"11","author":"Donovan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib116","author":"Brotherton"},{"key":"10.1016\/j.jadohealth.2011.07.003_bib117","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.ygyno.2010.01.028","article-title":"HPV vaccine and males: Issues and challenges","volume":"117","author":"Zimet","year":"2010","journal-title":"Gynecol Oncol"}],"container-title":["Journal of Adolescent Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054139X11002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054139X11002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T15:43:45Z","timestamp":1592927025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054139X11002382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1054139X11002382"],"URL":"https:\/\/doi.org\/10.1016\/j.jadohealth.2011.07.003","relation":{},"ISSN":["1054-139X"],"issn-type":[{"value":"1054-139X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}